• About Us
• Tumor Hypoxia
• Clinical Pipeline
  • Soft Tissue Sarcoma
  • Pancreatic Cancer
  • Hematological Malignancies
  • Antiangiogenics
  • [18F]HX4 Hypoxia PET Imaging
• Investors
  • News Releases
  • Webcasts
  • SEC Filings
  • Corporate Governance
  • Annual Reports
  • Investor FAQ
  • Email Alerts
  • Contact Information
• News & Resources
  • Scientific Presentations & Publications
• Careers
  • Current Opportunities

The Threshold team is made up of experienced research and clinical development scientists, clinicians, entrepreneurs, and business professionals with successful track records in the biotech industry. Members of our management team have played significant roles at industry leading companies including Affymax/Glaxo Wellcome, ALZA, Amgen, BMS, Camitro, Corixa/Coulter, Genentech, Gilead, Novartis, OSI, Protein Design Labs, Sanofi, Syntex, and Transcept.

• Harold E. Selick, Ph.D.
  Chief Executive Officer



• Tillman Pearce, M.D.
  Chief Medical Officer



• Mark D. Matteucci, Ph.D.
  Senior Vice President of Discovery Research



• Robert L. Simon
  Senior Vice President of Regulatory Affairs and Quality Assurance



• Stewart M. Kroll
  Senior Vice President of Clinical Operations and Biostatistics



• Charles P. Hart, Ph.D.
  Vice President of Biology



• Eric D. Malek, MBA
  Vice President of Corporate Development



• Joel A. Fernandes
  Vice President of Finance and Controller



• Nipun Davar, Ph.D., MBA
  Vice President of Pharmaceutical Development and Manufacturing

• Management Team
• Board of Directors